^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IPM001

    i
    Associations
    News

    Trials

    Company:
    Immupeutics Medicine
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Safety and Efficacy of Autoimmune Cell Therapy for Patients With Hepatocellular Carcinoma (NCT05105815)
    Phase 1
    Huashan Hospital
    Not yet recruiting
    Last update posted :
    11/03/2021
    Initiation :
    12/31/2021
    Primary completion :
    12/31/2023
    Completion :
    12/31/2024
    HLA-A
    |
    HLA-A*02
    |
    IPM001